Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and B Virus Infection

pyrazines has been researched along with B Virus Infection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashlock, BM; Bhatt, S; Diaz, LA; Lossos, IS; Mesri, EA; Ramos, JC; Toomey, NL1
Ambinder, RF; Chen, J; Chong, JM; Foss, CA; Fox, JJ; Fu, DX; Fukayama, M; Hobbs, RF; Kowalski, J; Pomper, MG; Sgouros, G; Tanhehco, Y1
Joyce, RM; Siddiqi, T1
Besa, E; Bray, P; Caro, J; Dulau Florea, A; Mahipal, A; Sbenghe, MM1
Chaudhary, PM; Matta, H1
Boulanger, E; Meignin, V; Oksenhendler, E1

Other Studies

6 other study(ies) available for pyrazines and B Virus Infection

ArticleYear
Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.
    The Journal of clinical investigation, 2013, Volume: 123, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; HEK293 Cells; Herpesviridae Infections; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Lymphoma, Primary Effusion; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Proteasome Inhibitors; Proto-Oncogene Proteins c-myc; Pyrazines; Tumor Suppressor Protein p53; Virus Latency; Virus Replication; Vorinostat; Xenograft Model Antitumor Assays

2013
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
    Nature medicine, 2008, Volume: 14, Issue:10

    Topics: Animals; Antineoplastic Agents; Arabinofuranosyluracil; Boronic Acids; Bortezomib; Burkitt Lymphoma; Cell Line, Tumor; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Iodine Radioisotopes; Male; Mice; Mice, SCID; Pyrazines; Radiopharmaceuticals; Sarcoma, Kaposi; Stomach Neoplasms; Thymidine Kinase

2008
A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab.
    Clinical lymphoma & myeloma, 2008, Volume: 8, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Doxorubicin; Herpesviridae Infections; Herpesvirus 8, Human; HIV; Humans; Immunohistochemistry; Liposomes; Lymphoma, Primary Effusion; Male; Positron-Emission Tomography; Pyrazines; Rituximab

2008
HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.
    The oncologist, 2012, Volume: 17, Issue:1

    Topics: Adult; Boronic Acids; Bortezomib; Castleman Disease; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV; Humans; Male; Pyrazines; Rare Diseases

2012
The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells.
    Cancer biology & therapy, 2005, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Proliferation; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, Non-Hodgkin; Pyrazines; Tumor Cells, Cultured

2005
Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma.
    British journal of haematology, 2008, Volume: 141, Issue:4

    Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, AIDS-Related; Lymphoma, Primary Effusion; Male; Middle Aged; Pyrazines

2008